Dr. Naseri entwickelt Plattformen zur nachhaltigen Biosynthese seltener Naturstoffe in Hefezellen (Pichia pastoris und Saccharomyces cerevisiae). Ihr aktueller Fokus liegt auf der Konstruktion von Werkzeugen zur präzisen Kontrolle von Genexpression — insbesondere künstliche Transkriptionsfaktoren und schnelle Genome-Editing-Techniken — um komplexe biosynthetische Stoffwechselwege in Mikroorganismen effizient zu assemblieren und zu optimieren. Dies ermöglicht Unternehmen in Pharmazie, Chemie und Biotechnologie, schwer zugängliche Naturstoffe (z. B. Wirkstoffe, Spezialchemikalien) kostengünstig und umweltschonend durch Fermentation herzustellen, statt sie aus der Natur zu extrahieren oder chemisch zu synthetisieren. Die Methoden adressieren ein Kernproblem der Metabolic Engineering: die Balance mehrerer Enzyme in langen Biosyntheserouten bei gleichzeitig robustem Zellwachstum.
🔒 Das System hat 235 mögliche Industrie-Partner gefunden — Firmen, Scores und Begründungen sind nur für eingeloggte Nutzer:innen sichtbar. Anmelden
Dr. rer. nat. Gita Naseri
HU-FIS-Profil ↗Förderer: DFG Nachwuchsgruppe Zeitraum: 04/2024 - 03/2030 Projektleitung: Dr. rer. nat. Gita Naseri
Förderer: DFG Nachwuchsgruppe Zeitraum: 04/2024 - 03/2027 Projektleitung: Dr. rer. nat. Gita Naseri
Nature Communications · DOI
In the first wave of synthetic biology, genetic elements, combined into simple circuits, are used to control individual cellular functions. In the second wave of synthetic biology, the simple circuits, combined into complex circuits, form systems-level functions. However, efforts to construct complex circuits are often impeded by our limited knowledge of the optimal combination of individual circuits. For example, a fundamental question in most metabolic engineering projects is the optimal level of enzymes for maximizing the output. To address this point, combinatorial optimization approaches have been established, allowing automatic optimization without prior knowledge of the best combination of expression levels of individual genes. This review focuses on current combinatorial optimization methods and emerging technologies facilitating their applications.
ACS Synthetic Biology · DOI
Control of gene expression by transcription factors (TFs) is central in many synthetic biology projects for which a tailored expression of one or multiple genes is often needed. As TFs from evolutionary distant organisms are unlikely to affect gene expression in a host of choice, they represent excellent candidates for establishing orthogonal control systems. To establish orthogonal regulators for use in yeast (Saccharomyces cerevisiae), we chose TFs from the plant Arabidopsis thaliana. We established a library of 106 different combinations of chromosomally integrated TFs, activation domains (yeast GAL4 AD, herpes simplex virus VP64, and plant EDLL) and synthetic promoters harboring cognate cis-regulatory motifs driving a yEGFP reporter. Transcriptional output of the different driver/reporter combinations varied over a wide spectrum, with EDLL being a considerably stronger transcription activation domain in yeast than the GAL4 activation domain, in particular when fused to Arabidopsis NAC TFs. Notably, the strength of several NAC-EDLL fusions exceeded that of the strong yeast TDH3 promoter by 6- to 10-fold. We furthermore show that plant TFs can be used to build regulatory systems encoded by centromeric or episomal plasmids. Our library of TF-DNA binding site combinations offers an excellent tool for diverse synthetic biology applications in yeast.
Nature Communications · DOI
Balanced expression of multiple genes is central for establishing new biosynthetic pathways or multiprotein cellular complexes. Methods for efficient combinatorial assembly of regulatory sequences (promoters) and protein coding sequences are therefore highly wanted. Here, we report a high-throughput cloning method, called COMPASS for COMbinatorial Pathway ASSembly, for the balanced expression of multiple genes in Saccharomyces cerevisiae. COMPASS employs orthogonal, plant-derived artificial transcription factors (ATFs) and homologous recombination-based cloning for the generation of thousands of individual DNA constructs in parallel. The method relies on a positive selection of correctly assembled pathway variants from both, in vivo and in vitro cloning procedures. To decrease the turnaround time in genomic engineering, COMPASS is equipped with multi-locus CRISPR/Cas9-mediated modification capacity. We demonstrate the application of COMPASS by generating cell libraries producing β-carotene and co-producing β-ionone and biosensor-responsive naringenin. COMPASS will have many applications in synthetic biology projects that require gene expression balancing.